Twist Bioscience Corporation (NASDAQ:TWST) Q3 2025 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. Welcome to Twist Bioscience's 2025 Third Quarter Financial Results Conference Call.
Twist Bioscience Corp (TWST)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | ARK Investment Management Catherine D. Wood | 6,400,441 | $235,472,218 | +3% | 1.73% |
| 2. | Point72 Asset Management Steve Cohen | 2,158,389 | $79,407,138 | +51% | 0.16% |
| 3. | Citadel Investment Group Ken Griffin | 1,503,546 | $55,315,457 | +41% | 0.01% |
| 4. | Tao Capital Nicholas J. Pritzker | 828,815 | $30,492,104 | 22.36% | |
| 5. | Millennium Management Israel Englander | 713,128 | $26,235,979 | +132% | 0.01% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $13.20 | 10,000 | $132,000.00 | 29,297 | 2023-05-10 | Filing | |
| $29.25 | 8,550 | $250,096.05 | 13,939 | 2022-05-11 | Filing | |
| $14.00 | 60,000 | $840,000.00 | 954,146 | 2018-11-02 | Filing | |
| $14.00 | 15,000 | $210,000.00 | 2,407,422 | 2018-11-02 | Filing | |
| $14.00 | 60,000 | $840,000.00 | 954,146 | 2018-11-02 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $28.36 | 186 | $5,275.70 | 49,780 | 2025-08-04 | Filing | |
| $28.36 | 5,585 | $158,412.94 | 639,721 | 2025-08-04 | Filing | |
| $28.36 | 1,255 | $35,596.82 | 126,206 | 2025-08-04 | Filing | |
| $28.36 | 785 | $22,265.74 | 103,827 | 2025-08-04 | Filing | |
| $28.36 | 3,189 | $90,452.80 | 235,153 | 2025-08-04 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 6,276,495 | $230,912,250 | 0% | |
| 2. | 5,831,311 | $214,533,931 | 0% | |
| 3. | 5,061,033 | $186,195,404 | 0.27% | |
| 4. | 3,906,604 | $143,723,961 | 0.38% | |
| 5. | 2,500,997 | $92,011,680 | 0% |
News See All
Is Twist Bioscience Corp. (TWST) Nearing Profitability?
Conestoga Capital Advisors, an asset management company, released its second-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Twist and Element Biosciences Expands Pact for Sequencing Workflow Solutions
Twist Bioscience Corporation (NASDAQ:TWST) is among the 11 Best Genomics Stocks to Buy According to Hedge Funds.
11 Best Genomics Stocks to Buy According to Hedge Funds
Genomics is the study of genes and how they operate.
Billionaire Nicholas J. Pritzker's 8 Stocks with Huge Upside Potential
Nicholas J. Pritzker is the chairman and co-founder of Tao Capital Partners, a San Francisco-based venture capital firm established in 2013.
Twist Bioscience Corporation (NASDAQ:TWST) Q2 2025 Earnings Call Transcript
Twist Bioscience Corporation (NASDAQ:TWST) Q2 2025 Earnings Call Transcript May 5, 2025Twist Bioscience Corporation misses on earnings expectations.
10 Worst High-Risk High-Reward Growth Stocks To Buy
On March 14, Tom Lee managing partner and head of research at Fundstrat Global Advisors appeared on a CNBC interview to talk about how the markets react to crises and what approach investors should take...
10 Best Immunology Stocks To Buy Now
Immunology is a rapidly advancing field with significant potential for growth, especially in the realm of biotech and pharmaceutical companies.
Cathie Wood's Stock Portfolio: 2025 Stock Picks
Cathie Wood is one of Wall Street's most contentious figures.
Twist Bioscience Corporation (NASDAQ:TWST) Q1 2025 Earnings Call Transcript
Operator: Good day. Thank you for standing by. Welcome to Twist Bioscience's 2025 First Quarter Financial Results Conference Call. At this time, all participants are in a listen-only mode.
Billionaire Hedge Funds
